Seth Meyers indicts the pharmaceutical industry and Martin Shkreli for price gouging

[iframe id=””%5D

On Tuesday’s Late Night, Seth Meyers took on big medicine as he reported on the latest from “Pharma Bro” Martin Shkreli. Last year, Shkreli’s company Turing Pharmaceuticals bought the license for the antiparasitic drug Daraprim, then raised the price from $13.50 to $750 per tablet, causing an uproar across the nation. But Seth points out that as bad as Shkreli is, this sort of price gouging is “standard operating procedure” in the medical industry. “He’s just doing what a lot of pharmaceutical companies already do. Except he’s being loud and conniving about it, while they’re being secretive and conniving about it.”

Shkreli appeared before the House Committee on Oversight and Government Reform last week and spent the entire time “doing what he does best: looking like a real slappable prick.” He wouldn’t answer a single question, pleading the fifth numerous times, including when Trey Gowdy asked him about a Wu Tang Clan album he bought for $2 million. The committee revealed an email from an unnamed pharmaceutical representative asking Shkreli not to raise the price of the drug—not because it’s wrong, but because it’s not worth the risk of drawing attention. “It’s like when you pull a heist and tell everyone don’t spend all the money right away, and then Shkreli goes out the next morning and spends $2 million on a Wu-Tang album.”


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s